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Abstract 
 
Background: Salvia gesneriflora Lindley is employed in traditional Mexican medicine for the treatment 
of  several diseases. This work reports the spasmolytic, anti-inflammatory and antioxidant activities of 
salvia gesneriflora  
Materials and Methods: The chromatographic profile of three extracts (SgH, SgD and SgM) of this 
plant allowed the identification of 11 components in SgH, the presence of rosmarinic (1), chlorogenic (2) 
and caffeic (3) acids and quercetin glucoside (4) in SgM and of ursolic acid (5) in SgD. The spasmolytic 
(electrically-induced contractions of guinea-pig ileum), anti-inflammatory (edema in mouse ear) and 
antioxidant potential (DPPH, ABTS and FRAP assays) of the extracts were evaluated.  
Results: SgM showed the highest percentage of relaxation (80.67 ± 1.633%) with no significant 
difference (p<0.05) when compared to the reference drug employed (Papaverine, 76.16 ± 2.44%), the 
EC50 was 66.89 ± 1.6 μg/mL, respectively for SgH and 26.88 ± 1.9 μg/mL for Papaverine. Anti-
inflammatory activity was 71.12 ± 4.9% for SgH, an effect which  is similar  to that of Indomethacin 
(reference drug) at the same dose (75.24 ± 2.4%). In the DPPH test, SsM reached the least CI50 
(1.16±1.08 µg/mL). For ABTS, SgH reached the least CI50 (1.73 ± 0.5 µg/mL) and for the FRAP assay, 
SgD showed the highest reductive capacity (1,782.08 ± 2.1 equivalent mM of FeSO4).  
Conclusion: S. gesneriflora extracts exhibited spasmolytic, anti-inflammatory and antioxidant activities; 
thus serving as co-adjuvants with regard to knowledge in the traditional medicine of this plant species and 
its application’s potential in other fields of pharmacy and foods.  
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13-acetate; DPPH, 2, 2-Diphenyl-1-pycrylHydrazyl; ABTS, 2, 2´-Azinobis-(3-ethylbenzothiazoline-6-
sulfonic acid); FRAP, Ferric Reducing Antioxidant Power; EC50, Effective Concentration ﬁfty; IC50, 
Inhibitory Concentration 50%. 
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Introduction 
 
One promising alternative in the search for new pharmaceuticals is made up of medicinal plants. 
In this respect, the genus Salvia, comprising more than 900 species, belongs to  Lamiaceae family, which 
is composed of 220 genera and approximately 4,000 species (Frodin, 2004; Wu et al., 2012). In Mexico, 
the genus Salvia is found in mountainous zones, mainly in the Central-South zone of Mexico, and some 
of these plants are employed in Mexican traditional medicine. In this regard, it has been reported that they 
possess anti-inflammatory, antimicrobial, antihypertensive activities and against central nervous system 
(CNS) disorders, among others (Aguilar et al., 1994; Herrera-Ruíz et al., 2006; Esquivel-Gutiérrez et al., 
2012; Bisio et al., 2015; Gómez-Rivera et al., 2018).  
In these zones, there are endemic species of this genus that are localized in coniferous forest, and 
among these is found the species Salvia gesneriflora Lindley, commonly known as myrtle. Its manner of 
employment is by cooking its aerial parts, and it is drunk for the treatment of stomach-ache and diarrhea 
(Monroy-Ortíz and Castillo-España, 2007). The only study found, to the of our knowledge, for this 
species is one report about the antiamebic and antigiardial activity of clerodane diterpenes from Mexican 
Salvias used for the treatment of diarrhea.  
These two diterpenes, identified as salvifulgenolide and isosalvixalapadiene were isolated from 
Salvia gesneriflora and presented low antiparasitic activity when compared against metronidazole 
(Calzada et al., 2015). Thus, to the best of our knowledge, their employment has not been validated 
within traditional medicine for the treatment of stomachache. The purpose of this work was to evaluate 
the spasmolytic, anti-inflammatory, and antioxidant potential of the three extracts of increasing polarity of 
the species Salvia gesneriflora Lindley. 
 
Materials and Methods  
 
Plant material 
 
Collection of the aerial parts (5 kg) of the plant was carried out in the town of Tres Marías, 
Hutizilac Municipality, state of Morelos, Mexico (19° 02’ 28.27’’ N; 99º 13’ 69.97’’ W. 2,735 msnm) in 
the month of November, 2015. A specimen was deposited at the HUMO-CIByC Herbarium of the 
Autonomous University of the State of Morelos (UAEM) for save-keeping and taxonomic identification 
(Voucher no. 33908) headed by Gabriel Flores-Franco. 
 
Preparation of plant extracts 
 
The plant material was oven-dried at 40°C for 3 days and pulverized in a Pulvex MPP300 mill. 
One kg of the plant material was macerated with hexane (10 L, Merck) in triplicate, this was filtered and 
vacuum-concentrated employing a rotary evaporator (Heidolph G3, German) at 40°C followed by 
lyophilization (Heto Dpywinner DW3) until obtaining a powder denominated hexanic extract (SgH). The 
dried plant residue was macerated with dichloromethane (10 L, Merck) and later with methanol (10L, 
Merck) following the same procedure as previously described, until obtaining the dichloromethane (SgD) 
and methanol (SgM) extracts, respectively. A portion of each extract was used for conducting the 
biological-activity assays that are described later. 
 From the maceration of 1 kg of the dried and milled plant material,  the following extracts in 
amounts and yields were obtained: SgH (8.3 g, 0.83%); SgD (12.3 g, 1.23%), and SgM (54.7 g, 5.47%).  
 
HPLC analysis 
 
 Chromatographic analysis was performed in a Waters 2695 Separation Module System equipped 
with a Waters 996 Photodiode Array Detector and Empower Pro software (Waters Corporation, USA). 
Chemical separation was achieved using a Supelcosil LC-F column (4.6 mm × 250 mm i.d., 5-µm particle 
size) (Sigma-Aldrich, Bellefonte, PA, USA). Mobile phase consisted of a 0.5% trifluoroacetic acid 
aqueous solution (solvent A) and acetonitrile (solvent B). The gradient system was as follows: 0-1 min; 
0% B; 2-3 min; 5% B; 4-20 min, 30% B; 21-23 min; 50% B; 24-25 min; 80% B; 26-27 100% B, and 28-
30 min, 0% B. The flow rate was maintained at 0.9 mL/min and sample injection volume was 10 µL.  
 Chromatographic separation of the SgM and SgD extracts and identification of rosmarinic acid 
(1), caffeic acid (2), chlorogenic acid (3), quercetin glucoside (4) and ursolic acid (5). 
 The SgM extract (50 g) was adsorbed on silica gel and applied to a silica gel column for gravity 
(150 g, 70-230 mesh, Merck, Darmstadt, Germany). A gradient of dichloromethane/methanol was utilized 
to elute the column, collecting 24 fractions that were grouped according to the TLC similarity of the 
compounds in nine (SgAg1-SgAg9) fractions of 500 mL each. The fractions were concentrated in a rotary 
evaporator under reduced pressure. Fractions SgAg5 and SgAg6 (3.6 g) were mixed and subjected to 
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chromatographic fractionation in a silica gel column and applied to a silica gel column (100 g, 70-230 
mesh, Merck). A gradient of n-dichloromethane/methanol was used to elute the column with an increase 
in polarity of 5%, collecting 51 fractions of 50 mL each. The fractions were grouped according to their 
similarity in terms of TLC in nine fractions (SgR1-SgR9). Fractions SgR4 and SgR5, on TLC, exhibited a 
single spot, which corresponded to quercetin glucoside (4, 35 mg) and  this was compared with a sample 
standard (Sigma, 90%) and Nuclear Magnetic Resonance (NMR) of 1H and 13C, while in fractions SgR8 
and SgR9, it was identified the presence of rosmarinic (1), caffeic (2) and chlorogenic (3) acids by High-
Performance Liquid Chromatography (HPLC) compared to sample  standards (1, Sigma,  98%; 2, 
Sigma,  98%; 3, Sigma, 95%). The Nuclear Magnetic Resonance (NMR) spectra were recorded on a 
Bruker Advance III HD-600 at 600 MHz for 1H and 13C at 150 MHz NMR in CD3OD. Chemical shifts 
reported ppm, while tetramethylsilane was utilized as internal reference. 
 The SgD extract was that with the lowest biological activity, thus,  it was not fractionated and 
only one compound was identified by TLC and HPLC, which corresponded to ursolic acid (5), compared 
to a standard sample (Sigma, 90%), and the presence of other compounds more polar than 5 was 
observed, which were not identified. 
 
GC-MS analysis of hexane extract (SgH) 
 
 The chemical composition of the SgH was analyzed on a Gas Chromatograph (GC) equipped with a 
quadruple mass detector in electron impact mode at 70 eV. Volatile compounds were separated on a HP 
5MS capillary column (25 m long, 0.2 mm i.d., with 0.3-µm film thickness). Oven temperature was set at 
40°C for 2 min, then programmed at 40‒260°C for 10°C/min and maintained for 20 min at 260°C. Mass 
detector conditions were as follows: interphase temperature 200°C and mass acquisition range, 20-550.  
 Injector and detector temperatures were set at 250 and 280°C, respectively. Splitless injection mode 
was carried out with 1 µL of each fraction (3 mg/mL solution). The carrier gas was helium at a flow rate of 1 
mL/min. Identification of volatiles was performed, comparing their mass spectra with those of the National 
Institute of Standards and Technology (NIST) 1.7 Library and comparing these with data in the literature 
(Adams, 2007).  
 
Spasmolytic and anti-inflammatory activities 
 
 Experiments were performed according to the Official Mexican Regulation NOM-062-ZOO-
1999 Guidelines (Technical Specifications for the Production, Care and Use of Laboratory Animals) and 
the international ethical guidelines for the care and use of experimental animals (Zimmermann, 1983). 
 
Model of guinea-pig isolated ileum  
 
 To evaluate the spasmolytic activity, the experimental model of electrically- induced guinea-pig 
isolated ileum was performed. Guinea-pigs of either sex (250-500 g) were used. Animals were maintained 
at a temperature of 22ºC ± 3ºC, with 70% ± 5% humidity, with 12-h light/dark cycles, and with 
food/water ad libitum and subjected to cervical dislocation. Their abdomens were opened. Their ileum 
was removed and maintained in Petri dishes containing Tyrode solution, constantly aerated with carbogen 
gas (95%, O2 +5% CO2 gas mixture). Portions of about 1.5 cm length of the isolated tissue were mounted 
in a set of 3 mL chambers. One end of the tissue was attached to the bottom of the chamber to an 
electrode while the other end  was attached with a silk thread to a force-displacement transducer, which 
was connected to an acquisition system (PanLab, BIOPAC Systems, USA). After 30 min adaptation 
period, the tissue was electrically stimulated (25 V, 5mS, 1 Hz, 5 S, every 2 min; with a Grass stimulator) 
by isolated tungsten electrodes connected to the end of the tissue. Induced contractions were recorded and 
after homogeneous responses were obtained, different concentrations of the drugs under study were added 
to the chamber and the ability to inhibit the electrically- induced contractions was evaluated (Cheng et al., 
2013; Escobar-Ramos et al, 2017). 
 The Tyrode solution was prepared with the following in mM: NaCl (137); C6H12O6 (5); NaHCO3 
(11.9): CaCl2.2H2O (2.7); KCl (5.4); MgCl2. 6H2O (0.5); NaH2PO4.H2O (0.45) and this was diluted to 2 L 
volume with distilled water. The pH was adjusted to 7.4. The extracts were diluted in Tyrode solution to 
obtain final concentrations in the bath of 50 to 200 μg/mL, which were compared with Papaverine as 
positive control. For  SgH, a dose-response curve (12.5-200 μg/mL) was obtained to determine the EC50. 
  
Anti-inflammatory activity 
 
 Male ICR mice weighing 25-30 g each, were utilized (n = 5 for each treatment). Mice were 
maintained at a temperature of 22ºC ± 3ºC, with 70% ± 5% humidity, with 12-h light/dark cycles, with 
food/water ad libitum.  
75 
 
 Animal inflammation was induced following the method previously described by Payá et al. 
1993. The dose evaluated for the extracts was 1.0 mg/ear. A control group received acetone as vehicle 
and Indomethacin Indo (Sigma) 1.0 mg/ear was utilized as anti-inflammatory positive control. 
 All extracts/drugs were dissolved in acetone and applied topically to both ears immediately after 
the administration of TPA. Six hours after administration of the inflammatory agent, the animals were 
sacrificed by cervical dislocation. Circular sections ( 6 mm in diameter) were taken from both the treated 
(t) and non-treated (nt) ears, and weighed to determine the magnitude of inflammation. Percentage of 
inhibition was obtained by using the following expression: 
  
Inhibition % = [(DW control - DW treatment)/Dw control] [100]  
Where: Dw = wt – wnt 
wt is the weight of the section of the treated ear 
wnt is the weight of the section of the non-treated ear. 
 
Evaluation of antioxidant capacity 
Antioxidant capacity for the 2, 2-Diphenyl-1-pycrylHydrazyl (DPPH) assay 
 
 For the DPPH assay, the method described by MacDonald-Wicks et al. (2006), was used with 
minor modifications. The activities of the extracts and reference compounds  measured by means of the 
targeting of a methanolic solution of 2,2-Diphenyl-1-pycryl-hydrazyl, purple-colored DPPH (Sigma).  
 25 µL of the different concentrations of the organic extracts (156.25, 312.5, 625, 1,250, 2,500, and 5,000 
µg/mL) were evaluated against 175 μL of a solution of DPPH (0.025 mg/mL). The target contained all of 
the reagents, with the exception of the positive control extracts, which included the following: the 
standardized extract of Camellia sinensis, which contains epigallocathequin-3-galate 94% (Teavigo®, 
2014). Absorbencies were measured in an Ultraviolet (UV)-Vis spectrophotometer at 515 nm, in an 
Enzyme-Linked Immuno-Sorbent Assay (ELISA) plate reader (Perkin-Elmer Lambda 40 UV-Vis). The 
determinations were carried out in triplicate. Percentage of inhibition was calculated according to the 
following expression:  
Inhibition (%) = [A0 – A1/A1] x100 
Where: A0 is the target absorbency and A1 is the absorbency of the extracts-to-evaluate.  
 The elaborated linear equation for each of the extracts was determined by linear regression 
analysis, and the inhibitory concentration 50% (IC50), defined as the concentration necessary to inhibit the 
formation of 50% of the DPPH radicals.  
 
Antioxidant capacity for 2, 2´-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assay 
 
 The antioxidant capacity of the  ABTS was estimated according to the method described by 
MacDonald-Wicks et al. (2006). In general, the ABTS- complex was produced in situ by the reaction of a 
solution of the 2, 2´-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) (Sigma) with potassium 
persulfate (Sigma). 230 μL were taken and mixed this with 20 µL of the extracts established for the 
DPPH assay. The target contained all the reagents except  the extracts and was also evaluated. The 
positive controls of the standardized extract of Camellia sinensis. Absorbences were read at 734 nm, 
while percentage of inhibition and inhibitory concentration 50% (IC50) were calculated according to the 
method described previously for the DPPH assay. The determinations were carried out in triplicate. 
 
Ferric Reducing Antioxidant Power (FRAP) assay 
 
 The FRAP assay was followed according to the method reported by Firuzi et al. (2005), with 
minor modifications. For the latter, the FRAP reagent was prepared by mixing the following: in a tampon 
of acetates 300 mM (3.1 g de CH3COONa in 16 mL of glacial acetic acid); 10-mM of 2, 4, 6-Tris-(2-
pyridyl)-s-triazine (TPTZ) (Sigma) in 40 mM of hydrochloric acid, and a 20-mM solution of FeCl3•6H2O, 
the latter at a 10:1:1 proportion (v/v). The extracts analyzed were at the concentrations previously 
indicated in the DPPH assay. 175 μL portions were taken from recent preparations of CARF reagent, 
incubated at 37°C, and together with a target of reagents, this was read at 595 nm. Later, 25 μL of the 
extracts at different concentrations and 50 μL of methanol were added. A calibration curve was prepared 
with a standard solution of FeSO4. Results were expressed as equivalent (mM) of FeSO4 per gram of 
extract. All experiments were carried out in triplicate.  
 
Statistical analysis  
 
 Results are expressed as  means ± standard error mean (SEM) of the means.  Statistical analyses 
were performed utilizing the SPSSTM ver. 23.0 statistical package and statistical differences were 
determined by means of analysis of variance (ANOVA) and the Tukey test. The EC50 was determined by 
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linear regression employing GraphPad PrismTM ver. 6.0 statistical software. Differences were considered 
significant at p <0.05. 
 
 
Results  
Chromatographic profile by HPLC of the SgM and SgD extracts 
  
 Analysis by high-performance liquid chromatography (HPLC) of the SgM extract (Figure 1) 
permitted us to identify a major compound, which displayed a retention time of 11.13 min (UV nm = 
221.6, 330.3), which corresponds to rosmarinic acid (1). The compounds with retention times at 8.83 min 
were identified as chlorogenic acid (2, UV nm = 242.7, 327.9 nm), at 9.24 min as caffeic acid (3, UV nm 
= 242.7, 325.5 nm), and at 9.54 min as quercetin glucoside (4, UV nm = 211, 255.7, 355.3 nm).  
 Identification of compounds 1 to 3 was performed by means of comparison with commercial 
standards and compound 4 was characterized by Nuclear Magnetic Resonance (NMR) of 1H and 13C and 
by comparison of the data of the chemical shifts with data described in the literature. 
 For the SgD extract (Figure 2), ursolic acid (5) was identified with a 27.92-min retention time 
and three compounds of higher polarity than were not identified, with retention times of 25.52, 25.88 and 
26.35 min were observed. 
 
Figure 1: HPLC chromatogram of SgH of Salvia gesneriflora. 
 
Figure 2: HPLC chromatogram of SgD of Salvia gesneriflora. 
 
Profile by GC-MS analysis of the SgH 
 
 Analysis of SgH by GC–MS identified 11 components, in the Table 1. These components are 
listed in order of elution, highlighting the presence of esterified aliphatic and aliphatic compounds such as 
hentriacontane (29.9%) and hecadecanoic acid, methyl ester (2.64%); sesquiterpenes such as spathulenol 
(3.35%) and triterpenes such as α, β-sitosterol (21.51 and 2.87%), β-amyrin (2.87%) and lupeol (6.46%). 
 
Table 1: Chemical composition of SgH 
Retention time (min) Molecular weight 
(a.m.u.) 
Compound %  
In the sample 
15.34 220 Spathulenol 3.35 
15.42 220 Caryophylene oxide 6.22 
18.93 270 Hexadecanoic acid, methyl ester 2.64 
19.59 284 Hecadecanoic acid, ethyl ester 0.45 
30.44 408 Nonacosane 9.33 
32.97 436 Hentriacontane 29.9 
36.44 464 Tritriacontane 17.26 
36.95 414 α-Sitosterol 21.51 
36.95 414 β-Sitosterol 2.87 
37.62 426 β-Amyrin 2.87 
38.64 426 Lupeol 6.46 
Characterization by NMR of the Isolated Compound (4) 
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 Chromatographic fractionation of SgF4 allowed us to obtain  compound (4) as a yellow powder 
that was compared with a standard sample (quercetin glucoside). In the UV light spectrum, the compound 
showed λmax at 211, 255.7, and 355.3 nm, which are distinctive of the flavonol structure. 
 According to these spectroscopic data analyses (Table 1) and by comparison with the data 
described in the literature, this compound (Figure 3) was identified as quercetin glucoside (Quercetin-3-
O-glucoside) (Abdelhady et al., 2015). 
 
O
OH
OH
HO
OH O
O
O OH
OH
OHOH  
Figure 3: Structure of the quercetin glucoside isolated from Salvia gesneriflora (4). 
 
Table 2: NMR spectroscopic data for compound 4 (600 MHz, CD3OD, δ ppm, J in Hz) 
Position Compound 4 
δ 13C-NMR δ 1H-NMR 
1 ---- --- 
2 158.58 --- 
3 135.92 --- 
4 179.68 --- 
5 162.25 --- 
6 98.64 6.20 (1H, dd, 2.1) 
7 164.76 --- 
8 94.87 6.40 (1H, d, 2.1) 
9 158.61 --- 
10 105.55 --- 
1´ 122.9 --- 
2´ 116.23 7.84 (1H, d, 2.1) 
3´ 145.95 6.86 (1H, d, 8.3) 
4´ 148.43 --- 
5´ 117.93 --- 
6´ 123.08 7.58 (1H, dd, 2.1, 8.3) 
1´´ 100.05 5.16 (1H, d, 7.7) 
2´´ 73.32 3.81-3.83, m 
3´´ 75.23 3.54-3.58, m 
4´´ 70.17 3.63-3.66, m 
5´´ 77.32 3.45-3.49, m 
6´´ a, b 62.09 3.83-3.87, m; 3.83-3.87, m 
 
Spasmolytic Activity 
 
 The results presented in Figure 4 demonstrate that all of the extracts of S. gesneriflora induced 
the concentration-dependent inhibition of the electrical stimulation-induced contractions in guinea-pig 
isolated ileum, using papaverine as positive control. At 200 μg/mL, the percentage relaxation achieved 
was 80.67 ± 1.63% for SgH, 52.41 ± 0.82% for SgD, and 54.99 ± 2.03% for SgM; in the case of 
papaverine at 100 μg/mL, this was 76.16 ± 2.44%. Statistical comparison among the extracts and against 
the papaverine revealed that SgH did not present a significant difference in percentage of relaxation (p 
<0.05). From the result of the statistical analysis, we carried out a dose-response curves of SgH and of 
papaverine (Figure 5), from which EC50 values of 66.89 ± 1.6 μg/mL for SgH and 26.88 ± 1.9 μg/mL for 
papaverine respectively, were obtained. 
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Figure 4: Dose-response curves of  SgH, SgD and SgM extracts from Salvia gesneriflora and papaverine 
(100 µg/mL)-induced contractions in guinea-pig ileum isolated. Values are reported as means ± standard 
error of the means (SEM). n = 5. ANOVA, Tukey *p<0.05 Papav100. 
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Figure 5: Dose-response curves of SgH and papaverine- induced contractions in guinea-pig ileum 
isolated. 
 
 
Anti-inflammatory Activity 
 
 The results corresponding to the anti-inflammatory effect of the extracts are presented in Figure 
6 where, at a same dose of 1.0 mg/ear, all of the extracts showed anti-inflammatory activities; the 
percentage of inhibition decreased according to the polarity of the solvent employed, that is, 71.12 ± 4.9% 
for SgH, 43.86 ± 4.1% for SgD, and 29.12 ± 0.3% for SgM. Statistical comparison among the extracts 
and against the reference drugs revealed that SgH did not present a significant difference in percentage 
inhibition of inflammation (p <0.05). 
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Figure 6: Percentage inhibition of inflammation (%) of SgH, SgD and SgM extracts from Salvia 
gesneriflora and Indo (Indomethacin) in edema induced by TPA in mouse ear at 1.0 mg/ear. Values are  
presented as means ± standard error of the means (SEM). n = 5. ANOVA, Tukey *p <0.05 Indo. 
 
Antioxidant Capacity of the Extracts of Salvia gesneriflora 
 
 The results obtained in the three assays in which the antioxidant capacity of the extracts from S. 
gesneriflora were evaluated are shown   in Table 2. In the DPPH assay, SgH extract presented very low 
antioxidant capacity in terms of the concentrations assayed; thus, it was not possible to determine their 
IC50; the highest IC50 reached (0.04 ± 0.09 µg/mL) was of Cs followed by SgM (1.16 ± 1.08 µg/mL).  
 Of the three extracts of S. gesneriflora evaluated in ABTS, SgH produced  the highest IC50 (1.73 
± 0.5 µg/mL), only surpassed by Cs (1.54 ± 0.6 µg/mL), while in the FRAP assay, SgD showed the 
greatest reductive capacity (1782.08 ± 2.1 Equivalent mM FeSO
4
). 
 
Table 3: Antioxidant capacity of the extracts (µg/mL) from Salvia gesneriflora at Inhibitory 
Concentration 50% (IC50) 
Extract DPPH IC50  (µg/mL) 
ABTS IC50  
(µg/mL) 
FRAP*  
Equivalent mM FeSO
4
 
SgH ND 1.73 ± 0.5 947.64 ± 2.0 
SgD 2.72 ± 0.07 1.93 ± 0.7 1782.08 ± 2.1 
SgM 1.16 ± 1.08 2.37 ± 0.6 1135.14 ± 2.2 
Cs 0.04 ± 0.09 1.54 ± 0.6 1612.64 ± 0.7 
Extracts SgH, SgD, SgM, and Cs (Camellia sinensis). Values are presented as means ± standard error of 
the means (SEM). n = 3. ND (Not Determined). *Determined for extracts at a concentration of 5,000 
µg/mL, and for the compounds, at a concentration of 2.5 mM. 
 
 
Discussion 
 
 The present study revealed that extracts SgH, SgD and SgM showed dose-dependent spasmolytic 
activity and diminished according to the polarity of the solvents employed to obtain the extracts, that is, 
SgH demonstrated the greatest inhibition of the electrically-induced ileal contractions. The EC50 of the 
extract was 2.49 times greater than that calculated for papaverine, whose effect could be associated with 
the presence of fatty acids such as hexadecenoic acid and hydrocarbons such as hentriacontane (major 
compound) as presented in the chromatographic profile. This finding  is in agreement with what has been 
reported for the genus Salvia.  in several of this species in which the antispasmodic activity has been 
evaluated,  for example, S. officinalis. Antispasmodic activity is associated with the presence of these 
groups of compounds. Therefore, in our study, fatty acids could be responsible for such activity (Kan et. 
al., 2011, Raal et. al., 2007). Similarly, for anti-inflammatory activity, SgH produced the highest activity, 
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similar to that of Indo at the same dose. This corroborated by hentriacontane wich exhibited suppressive 
potential on NO, PGE2 and LTB4 on LPS- induced translocation of NF-kB in RAW 264.7 (Khajuria et 
al.,2017). However, this was mainly due to the presence of compounds such as spathulenol which was 
tested in a pleurisy model that induces inhibition of inflammatory parameters such as leukocyte migration 
and protein extravasation (Do Nascimento, et al., 2018), and to the triterpenes, α, β-sitosterol, β-amyrin 
and lupeol that in various assay models, demonstrated high anti-inflammatory activity (Melo et al., 2011; 
Valerio et al., 2011; Sánchez-Burgosa et al., 2015). 
 In relation to antioxidant capacity by DPPH, SsM extract achieved the highest IC50, which is 
statistically similar to that achieved by Cs, which was used as reference extract. The elevated activity of 
SsM in this assay is probably  related to the presence of rosmarinic acid, as well as that of caffeic acid, 
chlorogenic acid and quercetin glucoside, which have been reported in various species of this genus and 
which possess high antioxidant capacity (Rungsimakan, et al., 2014; Bahadori et al., 2017; Zengin, et al., 
2018). Likewise, it is noteworthy that the SgH the extract showed the highest antioxidant capacity in the 
ABTS assay, demonstrating that it is the extract that has the least IC50 in comparison with the other two 
extracts. Thus, it is likely that the fatty acids and triterpenes previously mentioned in this assay again 
exhibited good activity. Finally, the greatest reductive capacity in the FRAP assay was for SgD, which 
reached highest equivalent mM of FeSO4, even surpassing those of Cs. The latter could be related to the 
presence of terpenic derivatives, which were identified in this species and which have been identified in 
Salvia species with antioxidant activity (Wang et al., 1998; Tepe et al., 2006; Bahadori et al., 2015; 
Alipić, 2017). 
 
Conclusion 
 
 Hexane, dichloromethane and methanol extracts of the aerial parts of Salvia gesneriflora 
produced spasmolytic, anti-inflammatory and antioxidant activities, in which compounds of the following 
types were identify: fatty acids; sterols; phenols and flavonoids. Therefore, these compounds may act as 
co-adjuvants in terms of the knowledge of traditional medicine of this species and suggests possible 
potential applications of the species in other fields of pharmacy and foods. 
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